Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CDY8P (Chromodomain Y-linked 8 pseudogene) is a non-protein-coding DNA sequence on the human Y chromosome, annotated as a pseudogene homologous to the chromodomain Y-linked gene family[2][4]. Pseudogenes are thought to arise through gene duplication or retrotransposition; they commonly accumulate mutations which disable their protein-coding capacity, rendering them nonfunctional as enzymes, receptors, or other molecular targets[8]. Most pseudogenes, including CDY8P, do not produce functional proteins; therefore, CDY8P is not considered a molecular target for therapeutic development, drug interaction, or as a biomarker. While some pseudogenes can play regulatory roles in gene expression via mechanisms such as competitive binding of regulatory RNAs, no such function has been described or demonstrated for CDY8P specifically[4][6][8].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromodomain Y-linked 8 pseudogene (CDY8P).